Clinical trial hints at Crohn’s treatment success

Clinical trial hints at Crohn’s treatment success
INITIAL clinical trial results are indicating mesenchymal stem cell (MSC) infusion is a viable treatment for patients suffering moderate to severe Crohn’s disease who are unresponsive to conventional therapy.
Cells from MSCs taken from the bone marrow of volunteer donors were injected into patients weekly for four weeks. 15 patients completed the trial: 12 of those showed a positive response to the treatment and disease remission was shown in 8.
Following on from the phase II trial, the group has planned a phase III clinical trial comparing MSC treatment with standard therapy (anti-TNF) in patients with advanced Crohn’s disease.

Read more: http://www.sciencewa.net.au/topics/health-a-medicine/item/2396-clinical-trial-hints-at-crohn%E2%80%99s-treatment-success.html

Image credit: Universidad Autónoma de Zacatecas